Tasos Konidaris, Executive Vice President & CFO at Amneal Pharmaceuticals, Inc. (AMRX), sold 100,000 shares at $8.91 ($891K) on 2025-03-05, disclosed to the SEC on 2025-03-07.
Seasonal sale ($891k) by Executive Vice President & CFO — this insider has traded AMRX in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.